StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 10/31/2013 -- StockRunway.com issues special report on – Oxygen Biotherapeutics, Inc.(NASDAQ:OXBT), Empire Resorts Inc(NASDAQ:NYNY), NuVasive, Inc.(NASDAQ:NUVA), Prana Biotechnology Limited (ADR)(NASDAQ:PRAN)
Oxygen Biotherapeutics, Inc.(NASDAQ:OXBT) stock is at $2.81, up +87.33 percent from its previous close of $1.50. The stock opened the session at $1.75 and touched its highest price point at $2.87.
Stocks graphical chart shows a bullish trend during its last one month’s trading session. It remained positive with +95.14% during previous three months trade. Its recent trading volume was 16.36 million shares in comparison to its usual trading volume of 383,510.00 shares. Oxygen Biotherapeutics, Inc., a development stage company, engages in developing biotechnology products that deliver oxygen to target tissues in the body primarily in the United States.
For How Long OXBT will Fight for Profitability? Read This Trend Analysis report
Empire Resorts Inc(NASDAQ:NYNY) stock is at $6.64 , up +25.28 percent from its previous close of $5.30. Its today’s volume is 1.39 million shares in comparison to its usual trading volume of 58,516.00 shares. The stock opened the session at $5.66 and touched its highest price point at $7.21.
NYNY’s quarterly performance remained green with the percentage of +108.22, while its year to date performance showed that the stock advanced overall +201.82%. Empire Resorts, Inc., through its subsidiaries, engages in hospitality and gaming industries in New York.
For How Long NYNY’s Gloss will Attract Investors? Find out via this report
NuVasive, Inc.(NASDAQ:NUVA) experienced a upsurge of +22.33% to a market valuation of $1.4B per share for previous trading session. After opening the day at $28.07 per share, volume surged to 3.64 million.
During last one month it rose with the percentage of +28.17. Its year to date performance remained progressive with +103.04%. NuVasive, Inc., a medical device company, engages in the design, development, and marketing of minimally disruptive surgical products and procedurally integrated solutions for the spine.
Will NUVA Continue To Move Higher? Find Out Here
Prana Biotechnology Limited (ADR)(NASDAQ:PRAN) opened its shares at the price of $3.70 for the day, its closing price was $4.40 after losing +19.89% for the day. The company traded with the total volume of 500.00 shares while its average trading aptitude remained 446,368.00 shares. The company has total of 40.74 million outstanding shares and its total market capitalization is $179.26 million. Prana Biotechnology Limited researches and develops therapeutic drugs for the treatment of neurological disorders in Australia.
Why Should Investors Buy PRAN After The Recent Gain? Just Go Here and Find Out
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)